![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 22202-22212, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Center For Blood Research and Department of Pathology,
Harvard Medical School, Boston, Massachusetts 02115
We find that monoclonal antibody YTA-1 recognizes
an epitope formed by a combination of the integrin
The Top of the Inserted-like Domain of the Integrin Lymphocyte
Function-associated Antigen-1
Subunit Contacts the
Subunit
-Propeller Domain near
-Sheet 3*
,
L and
2 subunits of LFA-1. Using
human/mouse chimeras of the
L and
2
subunits, we determined that YTA-1 binds to the predicted inserted
(I)-like domain of the
2 subunit and the predicted
-propeller domain of the
L subunit. Substitution into
mouse LFA-1 of human residues Ser302 and Arg303
of the
2 subunit and Pro78,
Thr79, Asp80, Ile365, and
Asn367 of the
L subunit is sufficient to
completely reconstitute YTA-1 reactivity. Antibodies that bind to
epitopes that are nearby in models of the I-like and
-propeller
domains compete with YTA-1 monoclonal antibody for binding. The
predicted
-propeller domain of integrin
subunits contains seven
-sheets arranged like blades of a propeller around a pseudosymmetry
axis. The antigenic residues cluster on the bottom of this domain in
the 1-2 loop of blade 2, and on the side of the domain in
-strand 4 of blade 3. The I domain is inserted between these blades on the top of
the
-propeller domain. The antigenic residues in the
subunit localize to the top of the I-like domain near the putative
Mg2+ ion binding site. Thus, the I-like domain contacts the
bottom or side of the
-propeller domain near
-sheets 2 and 3. YTA-1 preferentially reacts with activated LFA-1 and is a
function-blocking antibody, suggesting that conformational movements
occur near the interface it defines between the LFA-1
and
subunits.
*
This work was supported by Grant CA31798 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Biogen, Inc., Cambridge, MA 02142.
§
Present address: Millennium Pharmaceuticals, Cambridge, MA 02142.
¶
Present address: Pfizer Central Research, Groton, CT 06340.
To whom correspondence should be addressed: Center For Blood
Research and Dept. of Pathology, Harvard Medical School, 200 Longwood
Ave., Boston, MA 02115. Tel.: 617-278-3200; Fax: 617-278-3232.
This article has been cited by other articles:
![]() |
J. Zhu, B. Boylan, B.-H. Luo, P. J. Newman, and T. A. Springer Tests of the Extension and Deadbolt Models of Integrin Activation J. Biol. Chem., April 20, 2007; 282(16): 11914 - 11920. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li and L. Zhang The Fourth Blade within the {beta}-Propeller Is Involved Specifically in C3bi Recognition by Integrin {alpha}M{beta}2 J. Biol. Chem., September 5, 2003; 278(36): 34395 - 34402. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Luo, T. A. Springer, and J. Takagi High Affinity Ligand Binding by Integrins Does Not Involve Head Separation J. Biol. Chem., May 2, 2003; 278(19): 17185 - 17189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Mould, J. A. Askari, S. Barton, A. D. Kline, P. A. McEwan, S. E. Craig, and M. J. Humphries Integrin Activation Involves a Conformational Change in the alpha 1 Helix of the beta Subunit A-domain J. Biol. Chem., May 24, 2002; 277(22): 19800 - 19805. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Welzenbach, U. Hommel, and G. Weitz-Schmidt Small Molecule Inhibitors Induce Conformational Changes in the I Domain and the I-like Domain of Lymphocyte Function-associated Antigen-1. MOLECULAR INSIGHTS INTO INTEGRIN INHIBITION J. Biol. Chem., March 15, 2002; 277(12): 10590 - 10598. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ma, M. Shimaoka, C. Lu, H. Jing, C. V. Carman, and T. A. Springer Activation-induced Conformational Changes in the I Domain Region of Lymphocyte Function-associated Antigen 1 J. Biol. Chem., March 15, 2002; 277(12): 10638 - 10641. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Beals, A. C. Edwards, R. J. Gottschalk, T. W. Kuijpers, and D. E. Staunton CD18 Activation Epitopes Induced by Leukocyte Activation J. Immunol., December 1, 2001; 167(11): 6113 - 6122. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, C. Melchior, N. H. C. Brons, N. Schlegel, J. Caen, and N. Kieffer Probing Conformational Changes in the I-like Domain and the Cysteine-rich Repeat of Human beta 3 Integrins following Disulfide Bond Disruption by Cysteine Mutations. IDENTIFICATION OF CYSTEINE 598 INVOLVED IN alpha IIbbeta 3 ACTIVATION J. Biol. Chem., October 12, 2001; 276(42): 38628 - 38635. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Drbal, P. Angelisova, I. Hilgert, J. Cerny, P. Novak, and V. Horejsi A proteolytically truncated form of free CD18, the common chain of leukocyte integrins, as a novel marker of activated myeloid cells Blood, September 1, 2001; 98(5): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hogg and B. Leitinger Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1 J. Leukoc. Biol., June 1, 2001; 69(6): 893 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lu, M. Ferzly, J. Takagi, and T. A. Springer Epitope Mapping of Antibodies to the C-Terminal Region of the Integrin {{beta}}2 Subunit Reveals Regions that Become Exposed Upon Receptor Activation J. Immunol., May 1, 2001; 166(9): 5629 - 5637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lu, M. Shimaoka, Q. Zang, J. Takagi, and T. A. Springer Locking in alternate conformations of the integrin alpha Lbeta 2 I domain with disulfide bonds reveals functional relationships among integrin domains PNAS, February 27, 2001; 98(5): 2393 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zang and T. A. Springer Amino Acid Residues in the PSI Domain and Cysteine-rich Repeats of the Integrin beta 2 Subunit That Restrain Activation of the Integrin alpha xbeta 2 J. Biol. Chem., March 2, 2001; 276(10): 6922 - 6929. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Corps, C. Carter, P. Karecla, T. Ahrens, P. Evans, and P. Kilshaw Recognition of E-cadherin by Integrin alpha Ebeta 7. REQUIREMENT FOR CADHERIN DIMERIZATION AND IMPLICATIONS FOR CADHERIN AND INTEGRIN FUNCTION J. Biol. Chem., August 10, 2001; 276(33): 30862 - 30870. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Tan, M. K. Robinson, K. Drbal, Y. van Kooyk, J. M. Shaw, and S. K. A. Law The N-terminal Region and the Mid-region Complex of the Integrin beta 2 Subunit J. Biol. Chem., September 21, 2001; 276(39): 36370 - 36376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimaoka, C. Lu, R. T. Palframan, U. H. von Andrian, A. McCormack, J. Takagi, and T. A. Springer Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin alpha L I domains with high affinity and antagonist activity in vivo PNAS, May 22, 2001; 98(11): 6009 - 6014. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |